1. Home
  2. VTSI vs CTSO Comparison

VTSI vs CTSO Comparison

Compare VTSI & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

N/A

Current Price

$4.21

Market Cap

53.2M

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$0.73

Market Cap

45.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTSI
CTSO
Founded
1993
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
45.7M
IPO Year
1999
2008

Fundamental Metrics

Financial Performance
Metric
VTSI
CTSO
Price
$4.21
$0.73
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$7.00
$5.38
AVG Volume (30 Days)
28.8K
67.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$16,524,225.00
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
$13.39
$8.91
P/E Ratio
$47.78
N/A
Revenue Growth
5.57
48.53
52 Week Low
$3.57
$0.60
52 Week High
$7.47
$1.39

Technical Indicators

Market Signals
Indicator
VTSI
CTSO
Relative Strength Index (RSI) 45.00 54.78
Support Level N/A $0.62
Resistance Level $4.49 $0.84
Average True Range (ATR) 0.20 0.04
MACD 0.01 0.01
Stochastic Oscillator 43.19 59.46

Price Performance

Historical Comparison
VTSI
CTSO

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: